- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
NADIXA - 1% - 25g
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D10AF05 | G | Nadifloxacin - 1% | 6400 | 221671/08 | NADIXA | 1% | 25g | Cream | Topical | Spephal S.A.L. | Ferrer Internacional SA | Spain | 850,652 L.L | 23.08 | A2 | Ferrer Internacional SA | Spain | 2/5/2024 | 0 |